[High doses of anabolic steroids in collateral therapy of malignant neoplasms. Results with 19-norandrostenolone undecylate].
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000008:administration & dosage / Q000627:therapeutic use*; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*
D045930:Anabolic Agents; D009277:Nandrolone
Gli anabolizzanti steroidei in alte dosi nella terapia collaterale delle neoplasie maligne. Risultati con l'undecilato di 19-norandrostenolone.